Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure
Open accessThe DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure trial tested the hypothesis that continuous positive airway pressure (CPAP) would improve the survival rate without heart transplantation of patients who have central sleep apnea and heart failure. METHODS: After medical therapy was optimized, 258 patients who had heart failure (mean age [+/-SD], 63+/-10 years; ejection fraction, 24.5+/-7.7 percent) and central sleep apnea (number of episodes of apnea and hypopnea per hour of sleep, 40+/-16) were randomly assigned to receive CPAP (128 patients) or no CPAP (130 patients) and were followed for a mean of two years. During follow-up, sleep studies were conducted and measurements of the ejection fraction, exercise capacity, quality of life, and neurohormones were obtained. RESULTS: Three months after undergoing randomization, the CPAP group, as compared with the control group, had greater reductions in the frequency of episodes of apnea and hypopnea (-21+/-16 vs. -2+/-18 per hour, P<0.001) and in norepinephrine levels (-1.03+/-1.84 vs. 0.02+/-0.99 nmol per liter, P=0.009), and greater increases in the mean nocturnal oxygen saturation (1.6+/-2.8 percent vs. 0.4+/-2.5 percent, P<0.001), ejection fraction (2.2+/-5.4 percent vs. 0.4+/-5.3 percent, P=0.02), and the distance walked in six minutes (20.0+/-55 vs. -0.8+/-64.8 m, P=0.016). There were no differences between the control group and the CPAP group in the number of hospitalizations, quality of life, or atrial natriuretic peptide levels. An early divergence in survival rates without heart transplantation favored the control group, but after 18 months the divergence favored the CPAP group, yet the overall event rates (death and heart transplantation) did not differ (32 vs. 32 events, respectively; P=0.54). CONCLUSIONS: Although CPAP attenuated central sleep apnea, improved nocturnal oxygenation, increased the ejection fraction, lowered norepinephrine levels, and increased the distance walked in six minutes, it did not affect survival. Our data do not support the use of CPAP to extend life in patients who have central sleep apnea and heart failure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Clinically a high loop gain can express itself as periodic breathing, for example, at high altitude,357 or in congestive heart failure (CHF).358,359”
From International Consensus Statement on Obstructive Sleep Apnea (2023) · cites this paper as [359]
Citations
Cites
(2005) · Statistics for Biology and Health · doi:10.1007/0-387-27255-0_9 · Cited by 20,133
Rechtschaffen, A. (1968) · Medical Entomology and Zoology · Cited by 12,637
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., Fowler, M. B., Katus, H. A., Krum, H., Mohacsi, P., Rouleau, J. L., Tendera, M., Castaigne, A., Roecker, E. B., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442201 · Cited by 3,093
Redfield, M. M., Jacobsen, S. J., Burnett, J. C., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 3,004
Schuenemeyer, J. H., McCullagh, P., & Nelder, J. A. (1992) · Technometrics · doi:10.2307/1269238 · Cited by 2,667
McCullagh, P., & Nelder, J. A. (1983) · Springer eBooks · doi:10.1007/978-1-4899-3244-0 · Cited by 1,980
Effect of carvedilol on survival in severe chronic heart failure
Packer, M., Coats, A. J. S., & Fowler, M. B. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00477-9 · Cited by 1,661
EEG Arousals: Scoring Rules and Examples
(1992) · Sleep · doi:10.1093/sleep/15.2.173 · Cited by 1,637
Research works printed but not linked: 4
- Bradley TD, 2001, Can J Cardiol, 17, 677
- Staats BA, 1984, Am Rev Respir Dis, 130, 59
- Johnstone DE, 1994, Can J Cardiol, 10, 613
- 10.1172/jci21748 · doi:10.1172/jci21748 · Paper page
Cited by
Items 401–500 of 1,000
Wu, X., Fu, C., Zhang, S., Liu, Z., Li, S., & Jiang, L. (2015) · The Clinical Respiratory Journal · doi:10.1111/crj.12390 · Cited by 21
“Although acute benefit of CPAP on cardiovascular system is well-described (37), Naughton et al.”
BackgroundDoes home oxygen benefit people with chronic heart failure?
Clark, A., Johnson, M. J., & Squire, I. B. (2011) · BMJ · doi:10.1136/bmj.d234 · Cited by 21
“which might respond to nocturnal oxygen therapy. Sleep disordered breathing can be either obstructive sleep apnoea (common in patients with and without heart failure) or central sleep apnoea (common only in patients with chronic heart failure). Both types of sleep disordered breathing lead to episodic hypoxia, but onl…”
BackgroundArrhythmia Risk Associated with Sleep Disordered Breathing in Chronic Heart Failure
Mehra, R., & Redline, S. S. (2013) · Current Heart Failure Reports · doi:10.1007/s11897-013-0171-7 · Cited by 21
Sleep Apnea and Cardiovascular Disease
Logan, A. G., & Bradley, T. D. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0107-5 · Cited by 24
“The trial was a multicenter randomized controlled clinical trial in 258 heart failure patients with CSA who were receiving optimal medical therapy [46].”
BackgroundSelf-citationEnd-of-Life Care in the Treatment of Heart Failure in the Elderly
McClung, J. A. (2007) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2006.08.009 · Cited by 25
Sleep Apnea Syndrome: Implications on Cardiovascular Diseases
Bhadriraju, S., Kemp, C., Cheruvu, M., & Bhadriraju, S. (2008) · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine · doi:10.1097/hpc.0b013e31818ae644 · Cited by 23
Should sleep apnoea be a specific target of therapy in chronic heart failure?
Floras, J. S. (2008) · Heart · doi:10.1136/hrt.2008.142729 · Cited by 20
“15 events/h, which was the entry criterion for recruitment.(19) Because CPAP, as applied, did not eliminate CSA, the CANPAP trial was incapable of testing the mechanistic hypothesis that abolishing CSA would improve transplant-free survival.”
BackgroundMethodSelf-citationMapelli, M., Mattavelli, I., Salvioni, E., Banfi, C., Ghilardi, S., Martino, F. D., Gugliandolo, P., Mantegazza, V., Volpato, V., Basile, C., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.971108 · Cited by 19
“Importantly, a mechanical strategy based on nocturnal continuous positive airway pressure treatment to reduce sleep apneas failed to improve HF patients’ prognosis (39, 40) and, at present, no other disease-modifying HFrEF therapies have demonstrated to reduce CSA burden.”
MethodMalhamé, I., Bublitz, M. H., Wilson, D. L., Sanapo, L., Rochin, E., & Bourjeily, G. R. (2022) · Pregnancy Hypertension · doi:10.1016/j.preghy.2022.10.013 · Cited by 19
Huang, B., Huang, Y., Zhai, M., Zhou, Q., Ji, S., Liu, H., Zhuang, X., Zhang, Y., & Zhang, J. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14526 · Cited by 19
Central sleep apnoea in congestive heart failure
Malhotra, A., Patil, S. P., Sands, S. A., & Ayas, N. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00235-0 · Cited by 19
Nakazaki, C., Noda, A., Yasuda, Y., Nakata, S., Koike, Y., Yasuma, F., Murohara, T., & Nakashima, T. (2011) · Sleep And Breathing · doi:10.1007/s11325-011-0570-5 · Cited by 19
Influence of Cerebral Blood Flow on Central Sleep Apnea at High Altitude
Burgess, K. R., Lucas, S. J. E., Shepherd, K., Dawson, A. H., Swart, M., Thomas, K. N., Lucas, R. A. I., Donnelly, J., Peebles, K. C., Basnyat, R., et al. (2014) · SLEEP · doi:10.5665/sleep.4080 · Cited by 18
“”29 The isocapnic hypoxia was terminated when either: (1) PetO2 reached 45 mm Hg at sea level and 30 mm Hg at 5,050 m; (2) the VE exceeded 100 Lmin-1; or (3) the participant reached the end of”
MethodChowdhury, M., Adams, S., & Whellan, D. J. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.08.006 · Cited by 23
Sleep Disordered Breathing in Patients with Heart Failure: Pathophysiology and Management
Sharma, B. K., McSharry, D. G., & Malhotra, A. (2011) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-011-0145-6 · Cited by 18
Tamisier, R., Pépin, J., Cowie, M., Wegscheider, K., Vettorazzi, E., Suling, A. I., Angermann, C. E., d’Ortho, M., Erdmann, E., Simonds, A. K., et al. (2022) · Journal of Sleep Research · doi:10.1111/jsr.13694 · Cited by 19
“Studies investigating the effects of positive airway pressure (PAP) on CSA/CSR have reported conflicting results, with some showing beneficial effects while others have not (Arzt et al., 2013; Bradley et al., 2005; Naughton et al., 1995; Oldenburg et al., 2008; Pepperell et al., 2003).”
BackgroundPearls & Oy-sters: Treatment of central sleep apnea with topiramate
Westwood, A. J., Vendrame, M., Montouris, G., & Auerbach, S. H. (2012) · Neurology · doi:10.1212/wnl.0b013e318250d7bf · Cited by 18
Sleep-Disordered Breathing in Patients with Heart Failure
Mentz, R. J., & Fiuzat, M. (2014) · Heart Failure Clinics · doi:10.1016/j.hfc.2013.10.001 · Cited by 18
Joseph, S. M., & Costanzo, M. R. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.121 · Cited by 20
Bradley, T. D., & Floras, J. S. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201511-2198ed · Cited by 18
Self-citationTherapeutic Strategies for Sleep Apnea in Hypertension and Heart Failure
Noda, A., Miyata, S., & Yasuda, Y. (2013) · Pulmonary Medicine · doi:10.1155/2013/814169 · Cited by 19
“[12] found that CPAP resulted in attenuatedCSA, improved nocturnal oxygenation, increased LV ejection fraction, lowered norepinephrine levels, and extended distance walked in six minutes; however, it did not affect patient survival.”
BackgroundEnd-of-Life Care in the Treatment of Advanced Heart Failure in the Elderly
McClung, J. A. (2012) · Cardiology in Review · doi:10.1097/crd.0b013e31826d23ea · Cited by 18
“The use of continuous positive airway pressure in patients with sleep apnea secondary to heart failure has been demonstrated to have no effect on survival, however, reductions in apnea and norepinephrine levels have been documented, as well as increases in nocturnal oxygen saturation, EF, and distance walked in 6 minu…”
BackgroundGupta, A., Quan, S. F., Oldenburg, O., Malhotra, A., & Sharma, S. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9715-y · Cited by 17
Gullvåg, M., Gjeilo, K. H., Fålun, N., Norekvål, T. M., Mo, R., & Broström, A. (2019) · Scandinavian Journal of Caring Sciences · doi:10.1111/scs.12672 · Cited by 26
Obstructive sleep apnea and atrial fibrillation: understanding the connection
Oza, N. M., Baveja, S., Khayat, R., & Houmsse, M. (2014) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.2014.902748 · Cited by 20
“Interestingly, OSA treatment has been noted to improve ejection fraction, 6-min walk test performance and apnea status, but does not improve survival [60,61].”
BackgroundShort- and long-term effects of nocturnal oxygen therapy on sleep apnea in chronic heart failure
Bordier, P., Orazio, S., Hofmann, P., Robert, F., & Bourenane, G. (2014) · Sleep And Breathing · doi:10.1007/s11325-014-0982-0 · Cited by 17
Cardiovascular diseases and sleep apnea
Javaheri, S., & Somers, V. K. (2010) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52006-7.00020-4 · Cited by 17
Chokroverty, S. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7506-7525-3.50110-2 · Cited by 17
Síndromes de apneas-hipopneas durante el sueño e insuficiencia cardiaca
Arias, M. A., Rio, F. G., Alonso‐Fernández, A., & Sánchez, A. M. (2007) · Revista Española de Cardiología · doi:10.1157/13101645 · Cited by 24
“Tremel et al(47) 34 10 30 ± 10 28 (82) 7 (20) 21 (62)”
Mueller, A. S., Fietze, I., VOELKER, R., Eddicks, S., Glos, M., Baumann, G., & Theres, H. (2006) · Journal of Sleep Research · doi:10.1111/j.1365-2869.2006.00554.x · Cited by 17
“In contrast, a recent study did not reveal a reduction of survival by the use of continuous positive airway pressure (CPAP) in this patient group (Bradley et al., 2005).”
BackgroundPływaczewski, R., Brzecka, A., Bielicki, P., Czajkowska‐Malinowska, M., Cofta, S., Jończak, L., Radliński, J., Tażbirek, M., & Wasilewska, J. (2013) · Advances in respiratory medicine · doi:10.5603/arm.34100 · Cited by 33
Tekle, M. T., Bekalu, A. F., Getawa, S., Gelaye, K. A., & Gebreyohannes, E. A. (2021) · Vascular Health and Risk Management · doi:10.2147/vhrm.s322493 · Cited by 21
Bradley, T. D., Logan, A. G., & Floras, J. S. (2024) · European Respiratory Journal · doi:10.1183/13993003.01033-2024 · Cited by 18
Self-citationNeurologische Aspekte bei chronischer Herzinsuffizienz
Häusler, K. G., Laufs, U., & Endres, M. (2011) · Der Nervenarzt · doi:10.1007/s00115-010-3093-6 · Cited by 19
Altered Breathing Syndrome in Heart Failure: Newer Insights and Treatment Options
Tomita, Y., Kasai, T., Kisaka, T., Rossiter, H. B., Kihara, Y., Wasserman, K., & Daida, H. (2015) · Current Heart Failure Reports · doi:10.1007/s11897-014-0250-4 · Cited by 18
Priou, P., d’Ortho, M., Damy, T., Davy, J., Gagnadoux, F., Gentina, T., Meurice, J.-C., Pépin, J., Tamisier, R., & Philippe, C. (2015) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2015.09.007 · Cited by 16
Biomarkers in Patients with Heart Failure and Central Sleep Apnoea: Findings From the SERVE-HF Trial
Ferreira, J. P., Duarte, K., Woehrle, H., Cowie, M., Wegscheider, K., Angermann, C. E., d’Ortho, M., Erdmann, E., Levy, P. A., Simonds, A. K., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12521 · Cited by 17
“In the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnoea and Heart Failure study, 258 patients with HFrEF and CSA were randomly assigned to receive continuous positive airway pressure plus guideline-based medical treatment or guideline-based medical treatment alone.(5) After a median”
MethodImpact of Sleep on Cardiovascular Health: A Narrative Review
Sum‐Ping, O., & Geng, Y. (2022) · Heart and Mind · doi:10.4103/hm.hm_29_22 · Cited by 18
Exercise End-Tidal CO2 Predicts Central Sleep Apnea in Patients With Heart Failure
Čundrle, I., Somers, V. K., Johnson, B. D., Scott, C. G., & Olson, L. J. (2015) · CHEST Journal · doi:10.1378/chest.14-2114 · Cited by 17
Sleep-Disordered Breathing and Heart Failure
Brenner, S., Angermann, C., Jany, B., Ertl, G., & Störk, S. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2008.11.006 · Cited by 22
Sleep-Disordered Breathing in Patients with Heart Failure: New Trends in Therapy
Kazimierczak, A., Krzesiński, P., Krzyżanowski, K., & Gielerak, G. G. (2013) · BioMed Research International · doi:10.1155/2013/459613 · Cited by 21
Frontiers of Therapy for Patients With Heart Failure
Liu, S. S., Monti, J., Kargbo, H. M., Athar, M. W., & Parakh, K. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.04.033 · Cited by 20
Sleep disordered breathing in patients with heart failure
Krawczyk, M., Flinta, I., Garncarek, M., Jankowska, E. A., Banasiak, W., Germany, R. E., Javaheri, S., & Ponikowski, P. P. (2013) · Cardiology Journal · doi:10.5603/cj.2013.0092 · Cited by 16
Central sleep apnoea syndrome in chronic heart failure: an underestimated and treatable comorbidity
Müller, M., de Jong, M., Jaarsma, T., Koops, A., Voors, A. A., Nieuwenhuis, J. A., & Wijkstra, P. J. (2010) · Netherlands Heart Journal · doi:10.1007/bf03091773 · Cited by 16
Schmickl, C. N., Heckman, E. J., Owens, R. L., & THOMAS, R. J. (2019) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.7852 · Cited by 16
Cardiovascular Complications of Respiratory Diseases
Chowdhuri, S., Badr, M. S., Crook, E. D., & Taylor, H. A. (2007) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3180a7269e · Cited by 18
Síndrome de apneas-hipopneas durante el sueño y corazón
Santos, J. T., Álvarez, M. L. A., Guevara, J. C., Azcárate, J. M. A., & Canal, J. M. M. (2006) · Revista Española de Cardiología · doi:10.1157/13091373 · Cited by 20
Sleep and Breathing in Congestive Heart Failure
Rosen, D., Roux, F. J., & Shah, N. (2014) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2014.06.008 · Cited by 15
Tan, J. W. C., Leow, L. C., Wong, S., Khoo, S. M., Kasai, T., Kojodjojo, P., Duong‐Quy, S., Lee, C. P., Chirakalwasan, N., Li, H., et al. (2022) · European Cardiology Review · doi:10.15420/ecr.2021.59 · Cited by 17
Cardiovascular Effects of Mechanical Ventilation and Weaning
Frazier, S. K. (2008) · Nursing Clinics of North America · doi:10.1016/j.cnur.2007.10.001 · Cited by 15
Satake, H., Sugimura, K., Fukumoto, Y., Fukuda, K., Nakano, M., Kondo, M., Fukui, S., Ogawa, H., Shinozaki, T., & Shimokawa, H. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0702 · Cited by 15
Sleep-Disordered Breathing During Congestive Heart Failure: To Intervene or Not to Intervene?
Valika, A. A., & Costanzo, M. R. (2017) · Cardiac failure review · doi:10.15420/cfr.2017:7:1 · Cited by 16
“In the Canadian Positive Airway Pressure Trial for Patients with Congestive HF and Central Sleep Apnea (CANPAP) trial in 258 optimally treated HF patients with an LVEF <40 % and AHI >15 events/h, compared to control, CPAP did not prolong transplant-free survival, despite reduction of AHI from 40 to 19 events/h, improv…”
The reversal of cardiology practices: interventions that were tried in vain.
Prasad, V. K., & Cifu, A. S. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2223-3652.2013.10.05 · Cited by 15
“And, indeed, the Canadian Positive Airway Pressure trial (39) found that, among 258 patients with OSA and CHF (who were awaiting heart transplant) that use of CPAP could improve cardiac EF, decrease circulating norepinephrine, and decrease nocturnal episodes of apnea.”
BackgroundPataka, A., & Riha, R. L. (2013) · Current Cardiology Reports · doi:10.1007/s11886-013-0385-z · Cited by 17
Treatment options in Cheyne-Stokes respiration
Randerath, W. J. (2010) · Therapeutic Advances in Respiratory Disease · doi:10.1177/1753465810379008 · Cited by 15
Control of Breathing and Upper Airways During Sleep
Horner, R. L., & Malhotra, A. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-3383-5.00085-3 · Cited by 21
Ventricular assist devices and sleep-disordered breathing
Akkanti, B. H., Castriotta, R. J., Sayana, P., Nunez, E., Rajapreyar, I. N., Kumar, S., Nathan, S. S., & Majid, R. (2016) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2016.08.002 · Cited by 15
“With regard to the use of CPAP in CSA, the results of the Canadian continuous positive airway pressure for patients with central sleep apnea and heart failure trial (CANPAP) are most important.”
BackgroundInfluentialKasai, T., Taranto‐Montemurro, L., Yumino, D., Wang, H., Floras, J. S., Newton, G. E., Mak, S. S., Ruttanaumpawan, P., Parker, J. D., & Bradley, T. D. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12808 · Cited by 16
Self-citationSchwartz, A. R., Goldberg, L. R., McKane, S. W., & Morgenthaler, T. I. (2021) · Sleep And Breathing · doi:10.1007/s11325-021-02335-x · Cited by 16
Treatment of obstructive and central sleep apnoea in heart failure: practical options: Table 1—
Javaheri, S. (2007) · European Respiratory Review · doi:10.1183/09059180.00010607 · Cited by 15
“Despite early enthusiasm, unfortunately, long-term CPAP therapy does not improve the number of hospitalisations, quality of life or survival of patients with heart failure and CSA [ 33 ].”
BackgroundInfluentialComplex sleep apnea: the hedgehog and the fox
Brown, L. K., & Casey, K. R. (2007) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3282f1479b · Cited by 15
Sleep apnea in chronic heart failure
Anselm, A. H., Gauthier, N., Beanlands, R. S., & Haddad, M. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3282f323ce · Cited by 18
Feng, G., Zhuge, P., Zhang, Z., & Ma, J. (2024) · Sleep And Breathing · doi:10.1007/s11325-024-03107-z · Cited by 15
Fodor, A. C., Huțanu, D., Budin, C. E., Ianoși, M. B., Rachiș, D.-L., Sárközi, H.-K., Vultur, M. A., & Jimborean, G. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14072369 · Cited by 13
“However, studies show that overall survival was not improved significantly in these patients, as proved in the CANPAP trial [29].”
Sleep apnoea in patients with heart failure: Part II: Therapy
Bordier, P. (2009) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2009.06.005 · Cited by 15
Management of Comorbid Conditions in Heart Failure
Nagarajan, V., & Tang, W. H. W. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.07.006 · Cited by 16
Combes, N., Jaffuel, D., Cayla, G., Granier, M., Borel, J., Corne, P., Jonquet, O., Jaber, S., Davy, J. M., & Pépin, J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.12.007 · Cited by 14
End-of-Life Care in the Treatment of Heart Failure in Older Adults
McClung, J. A. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.02.014 · Cited by 14
Kwon, Y., Logan, J. G., Pusalavidyasagar, S. S., Kasai, T., Cheong, C., & Lee, C. (2019) · Sleep Medicine Research · doi:10.17241/smr.2019.00493 · Cited by 15
“This could possibly be due to insufficient suppression of CSA, observed in about half of the participants in the CPAP group [72,73].”
BackgroundWang, J., Covassin, N., Dai, T., Fan, Z., Yisilamu, P., Sun, D., Li, F., & Xie, J. (2021) · Heart & Lung · doi:10.1016/j.hrtlng.2021.01.012 · Cited by 17
Effect of Zolpidem on nocturnal arousals and susceptibility to central sleep apnea
Ahmad, B., Sankari, A., Eshraghi, M., Aldwaikat, A., YARANDI, H. N., Zeineddine, S., Salloum, A., & Badr, M. S. (2022) · Sleep And Breathing · doi:10.1007/s11325-022-02593-3 · Cited by 15
Sleep-disordered breathing and cardiovascular disease: who and why to test and how to intervene?
Vazir, A., & Kapelios, C. J. (2023) · Heart · doi:10.1136/heartjnl-2019-316375 · Cited by 15
Central sleep apnea in patients with congestive heart failure
Badr, S. M. (2008) · Heart Failure Reviews · doi:10.1007/s10741-008-9100-3 · Cited by 16
“The Canadian Continuous Positive Airway Pressure trial, or CANPAP [63], tested the hypothesis that CPAP would improve the survival rate without heart transplantation in patients with heart failure and central sleep apnea.”
MethodCardiorespiratory fitness and sleep-related breathing disorders
Vanhecke, T. E., Franklin, B. A., Ajluni, S., Sangal, R. B., & McCullough, P. A. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.5.745 · Cited by 14
Management of End-Stage Heart Failure
Murthy, S., & Lipman, H. I. (2011) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2011.03.007 · Cited by 15
Continuous Positive Airway Pressure for the Treatment of Sleep Apnea
Chowdhuri, S. (2007) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2007.04.011 · Cited by 17
Acute Effects of Nasal CPAP in Patients With Hypertrophic Cardiomyopathy
Nerbass, F. B., Salemi, V. M. C., Pedrosa, R. P., Portilho, N. D. P., Ferreira‐Filho, J., Moriya, H. T., Antunes, M. D. O., Arteaga-Fernández, E., Drager, L. F., & Lorenzi‐Filho, G. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.05.004 · Cited by 14
Management of Sleep Apnea Syndromes in Heart Failure
Selim, B. J., & Ramar, K. (2016) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2016.10.004 · Cited by 15
Novel Devices in Heart Failure
Zeitler, E. P., & Abraham, W. T. (2020) · JACC Heart Failure · doi:10.1016/j.jchf.2019.11.006 · Cited by 15
A novel approach to the treatment of central sleep apnea in patients with heart failure
Augostini, R. S. (2012) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-011-0165-7 · Cited by 15
After the SERVE-HF Trial, Is There Still a Need for Treatment of Central Apnea?
Emdin, M., Passino, C., & Giannoni, A. (2015) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2015.09.005 · Cited by 14
Heart failure and sleep-disordered breathing
Zhai, A. B., Yip, A., & Haddad, H. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000263 · Cited by 13
“The Canadian continuous positive airway pressure for patients with central sleep apnea and heart failure (CANPAP) study enrolled 258 patients and was able to demonstrate benefit of CPAP to attenuate CSA and improve oxygenation, or even possibly LVEF, but not survival [58].”
BackgroundKundel, V., Ahn, A. P., Arzt, M. E., Asin, J., Azarbarzin, A., Collop, N. A., Das, A. M., Fang, J. C., Khayat, R., Penzel, T., et al. (2024) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.11424 · Cited by 16
Javaheri, S. (2010) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2010.05.006 · Cited by 13
Insights on mandibular jaw movements during polysomnography in obstructive sleep apnea
Malhotra, A., Martinot, J., & Pépin, J. (2023) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.10830 · Cited by 15
Recognition and Management of Sleep-Disordered Breathing in Chronic Heart Failure
Kahwash, R., Kikta, D. G., & Khayat, R. (2010) · Current Heart Failure Reports · doi:10.1007/s11897-010-0037-1 · Cited by 13
“The Canadian Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure (CANPAP) [ 36 ] trial is the largest prospective randomized controlled trial to date testing the efficacy of nocturnal CPAP in reducing mortality and transplant-free survival in patients with advanced heart failure.”
BackgroundHeart failure and sleep-disordered breathing: mechanisms, consequences and treatment
Kee, K., & Naughton, M. T. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e3283319a87 · Cited by 15
Yang, H., & Sawyer, A. M. (2016) · Heart & Lung · doi:10.1016/j.hrtlng.2016.02.002 · Cited by 13
Chen, W., Gillett, E. S., Khoo, M. C. K., Ward, S. L. D., & Nayak, K. S. (2017) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.25675 · Cited by 13
Prognostic value of sleep apnea and nocturnal hypoxemia in patients with decompensated heart failure
Huang, Y.-H., Wang, Y., Huang, Y., Zhai, M., Zhou, Q., Zhao, X., Tian, P., Ji, S., Zhang, C., Zhang, Y., et al. (2020) · Clinical Cardiology · doi:10.1002/clc.23319 · Cited by 15
“Phrenic nerve stimulation has been shown effective to improve AHI and hypoxemia in patients with CSA.34 A randomized controlled trial has been registered to assess the efficacy of an oral appliance for sleep-disordered breathing and cardiac function in patients with heart failure.35 These novel therapeutic approaches…”
BackgroundInfluentialPalliative symptom management in patients with heart failure
Zambroski, C. H., & Bekelman, D. B. (2008) · Progress in Palliative Care · doi:10.1179/096992608x346206 · Cited by 13
Clinical Assessmentof Heart Failure: Utility of Symptoms, Signs, and Daily Weights
Vader, J. M., & Drazner, M. H. (2009) · Heart Failure Clinics · doi:10.1016/j.hfc.2008.11.001 · Cited by 18
Mirzaaghazadeh, M., Bahtouee, M., Mehdiniya, F., Maleki, N., & Tavosi, Z. (2014) · Sleep Disorders · doi:10.1155/2014/978358 · Cited by 15
Aslan, G., Afşar, B., Siriopol, D. C., Kanbay, A., Sal, O., Benli, C., Okcuoglu, J., Covic, A. C., & Kanbay, M. (2017) · Angiology · doi:10.1177/0003319717709175 · Cited by 16
Sleep‐Disordered Breathing in Recipients of Implantable Defibrillators
Grimm, W., Sharkova, J., HEITMANN, J., Jerrentrup, A., Koehler, U., & Maisch, B. (2009) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.02219.x · Cited by 13
Sleep Apnea and Cardiovascular Diseases
Álvarez-Sala, R., Rio, F. G., del Campo, F., Zamarrón, C., & Netzer, N. C. (2014) · Pulmonary Medicine · doi:10.1155/2014/690273 · Cited by 13
Sinha, A.-M., Skobel, E. C., & Breithardt, O.-A. (2006) · New England Journal of Medicine · doi:10.1056/nejmc053389 · Cited by 14
van Es, V. A. A., Lathauwer, I. L. J. D., Kemps, H., Handjaras, G., & Betta, M. (2024) · Bioengineering · doi:10.3390/bioengineering11101045 · Cited by 13
Al-Farsi, H. Y., Al-Fahdi, E. Y., Al-Balushi, M. A., Al-Jahwari, A. N., Al-Maskari, A., & Das, S. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673350476250331181123 · Cited by 16
Schroll, S., Sériès, F., Lewis, K. E., Benjamin, A., Escourrou, P., Luigart, R., Pfeifer, M. A., & Arzt, M. E. (2013) · Respirology · doi:10.1111/resp.12193 · Cited by 12
Self-citation
Metadata
- Authors
- Bradley, T. D., Logan, A. G., Kimoff, R. J., Sériès, F., Morrison, D., Ferguson, K., Belenkie, I., Pfeifer, M., Fleetham, J., Hanly, P., Smilovitch, M., Tomlinson, G., & Floras, J. S.
- Affiliations
- University of Toronto (CA)
- McGill University (CA)
- Université Laval (CA)
- Dalhousie University (CA)
- Western University (CA)
- University of Calgary (CA)
- University of Regensburg (DE)
- University of British Columbia (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-11-10
- Volume
- 353
- Issue
- 19
- Pages
- 2025-2033
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2130637800
- Semantic Scholar
- 266ff6f4028ab04f061c1b59c2a17a2fc2990e32
- Cited by
- 1,189
- References
- 45
- Citations by year
- 2026: 16 · 2025: 31 · 2024: 33 · 2023: 47 · 2022: 45 · 2021: 51 · 2020: 40 · 2019: 55 · 2018: 50 · 2017: 70 · 2016: 87 · 2015: 68 · 2014: 44 · 2013: 67 · 2012: 62
- FWCI
- 45.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Respiratory Support and Mechanisms
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- continuous positive airway pressure, central sleep apnea, heart failure, nocturnal oxygen saturation, norepinephrine, ejection fraction, exercise capacity, neurohormones, atrial natriuretic peptide, quality of life, heart transplantation, sleep-disordered breathing, heart failure with reduced ejection fraction, heart failure with preserved ejection fraction
- MeSH terms
- Aged, Female, Follow-Up Studies, Heart Failure, Humans, Male, Middle Aged, Norepinephrine, Stroke Volume, Survival Rate, Proportional Hazards Models, Heart Transplantation, Treatment Outcome, Exercise Tolerance, Sleep Apnea, Central, Continuous Positive Airway Pressure
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.